Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2011 Results
Date:11/14/2011

lion) for the third quarter of 2011, which represented a decrease of 37.8% from RMB54.7 million for the same period in 2010. Net margin, representing net income attributable to Simcere divided by total revenue, was 6.8% for the third quarter of 2011, compared to 9.9% for the same period in 2010. For the first nine months of 2011, net income attributable to Simcere was RMB135.6 million (US$21.3 million), which represented an increase of 19.2% from RMB113.7 million for the same period in 2010. Net margin for the first nine months of 2011 was 8.9%, compared to 7.3% for the same period in 2010.

Basic and diluted earnings per American Depository Share ("ADS")for the third quarter of 2011 were RMB0.64 (US$0.10) and RMB0.61 (US$0.10), respectively. Basic and diluted earnings per ADS for the first nine months of 2011 were RMB2.54 (US$0.40) and RMB2.45 (US$0.38) respectively. One ADS represents two ordinary shares of the Company.

As of September 30, 2011, the Company had cash, cash equivalents and restricted cash of RMB208.2 million (US$32.6 million), compared to RMB278.7 million as of December 31, 2010.

Share Repurchase ProgramIn November 2011, the Company's board of directors approved a share repurchase program, under which the Company may purchase up to US$30 million of its issued and outstanding ADSs. The repurchases will be made from time to time on the open market at prevailing market prices or in block trades and subject to restrictions relating to volume, price and timing. The Company may effect repurchase transactions pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The timing and extent of any repurchases will depend upon market conditions, the trading price of its ADSs and other factors. The Company expects to implement this share repurchase program in the next 12 months, in a manner consistent with market condit
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
3. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
4. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
11. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013   Accuray ... today the publication of study results involving hundreds ... Robotic Radiosurgery System, the most widely used form ... study followed 304 patients for a median of ... and found that 97 percent of patients with ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... MIRAGE, Calif., March 27 In the medical,community at ... attacks kill,and destroy cells in the heart muscle. Multiple ... stimulate the heart to repair,itself after an individual suffers ... The Weil Institute of Critical Care Medicine, located in ...
... Discovery Support Program, HAMBURG, Germany and ... (Frankfurt Stock Exchange: EVT) announced today that ... Japan) signed a new drug,discovery agreement targeting ... collaboration applies Evotec,s proprietary fragment-based drug,discovery platform, ...
Cached Medicine Technology:Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 3
(Date:5/21/2013)... risk of sudden infant death syndrome (SIDS) is five ... new study finds. British researchers noted that bed-sharing ... not drink, use illegal drugs or smoke. They advised ... of infant death in developed countries, would drop dramatically ... In the United States, all parents are advised to ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... 2013 Residents in St. Petersburg, FL ... now that Dr. David Sherberg, DMD, has joined Coast ... Dr. Sherberg provides preventive, restorative and cosmetic dentistry to ... friendly team provide a wide variety of services ... canal therapy, crowns, bridges, dentures, dental implant restorations, veneers, ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a little easier ... Kit including all the essentials a glowing bride or ... Wedding Day. , TheBeautyPlace.com features Wedding Day essentials to ... Day. Flowers blooming and warmer weather indicates the springtime, ... Memorial Day to October, brides to be can finally ...
(Date:5/21/2013)... Dr. Francine Kaufman , inventor of Extend ... patients in the 1980s: It weighed several pounds and was jokingly ... it could only be used in the hospital setting. , The ... the advantages are greater as well. The insulin pump is now ... often on a belt or a pocket. It delivers fast-acting insulin ...
Breaking Medicine News(10 mins):Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4
... A group ... Jackson Healthcare. The Hospital Charitable Service Awards have been created to find and celebrate ... ... A group of senior healthcare executives have joined forces to launch a new awards program ...
... BOSTON (May 25, 2010) Longtime environmental health ... the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous ... In a review article published online May 25 ... express the need for more complex strategies for ...
... a new influenza vaccine that brings science one step closer ... for seasonal flu shots. The new findings can be ... first online, open-access journal published by the American Society for ... narrow range of influenza virus strains," said Peter Palese, Ph.D., ...
... Suggestions include ,presumed consent, and priority for those who pledge ... transplants save thousands of lives every year, but many more ... of organs. While proposals to increase the supply have ... -- or even if they should be tried at all. ...
... ... and earn money for college, by entering the B’nai B’rith International Diverse Minds Youth ... grade-schoolers about tolerance and diversity. The winners take home $5,000 college scholarships and will ... ...
... Arnhem -- On 8 May an editorial about the Reduction ... H. Schrder and Monique J. Roobol was published in the ... of the European Association of Urology (EAU). The ... 1, 2010 in the New England Journal of Medicine ...
Cached Medicine News:Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 2Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 3Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 4Health News:Endocrine-disrupting chemicals pose cancer risk 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 3Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2Health News:European Urology: Editorial about REDUCE trial underlines value of dutasteride 2
... ago, Zyderm® and Zyplast® injectable collagen implants ... for smoothing facial lines, wrinkles and scars ... supplement the skins natural collagen, require minimal ... more than one million people worldwide have ...
... Captique is a non-animal stabilized ... newest HA filler to enter the ... correction of moderate to severe facial ... folds). Captique is injected just under ...
... Radiesse brings you into the new ... can now offer your patients immediate, long-term ... and flexibility. This injectable filler offers superior ... cosmetic and reconstructive treatments. Long-lasting, Radiesse saves ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
Medicine Products: